Comparison of preovulatory follicular concentrations of epidermal growth factor, insulin-like growth factor-I, and inhibins A and B in women undergoing assisted conception treatment with gonadotropin-releasing hormone (GnRH) agonists and GnRH antagonists

Fertility and Sterility

Volumn 87, Issue 4, 2007, Pages 995-998

  Ulug, Ulun ^a   Turan, Ersadik ^a   Tosun, Suleyman B ^a   Erden, Halit Firat ^a   Bahceci, Mustafa ^a  

^a German Hospital in Istanbul   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; EPIDERMAL GROWTH FACTOR; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; INHIBIN A; INHIBIN B; LEUPRORELIN; SOMATOMEDIN C;

ADULT; ARTICLE; CONCEPTION; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; OOCYTE; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL;

ADULT; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; ESTRADIOL; FEMALE; FOLLICULAR FLUID; GONADOTROPIN-RELEASING HORMONE; HUMANS; INHIBINS; INSULIN-LIKE GROWTH FACTOR I; OOCYTE DONATION; PROGESTERONE; PROSPECTIVE STUDIES; REPRODUCTIVE TECHNIQUES, ASSISTED; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 34047259818     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.08.102     Document Type: Article

References (27)

1. Olivennes F., Cunha-Filho J.S., Fanchin R., Bouchard P., and Frydman R. The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 8 (2002) 279-290
2. Albano C., Felberbaum R.E., Smitz J., Riethmuller-Winzen H., Engel J., Diedrich K., et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 15 (2000) 526-531
3. Felberbaum R.E., Albano C., Ludwig M., Riethmuller-Winzen H., Grigat M., Devroey P., et al. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Hum Reprod 15 (2000) 1015-1020
4. Olivennes F., Belaisch-Allart J., Emperaire J.C., Dechaud H., Alvarez S., Moreau L., et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 73 (2000) 314-320
5. Hsueh A.J., and Erickson G.F. Extrapituitary action of gonadotropin-releasing hormone: direct inhibition ovarian steroidogenesis. Science 204 (1979) 854-855
6. Gaetje R. IGF-I and EGF influence on steroid secretion and morphology of human granulosa cells of IVF-cycles and natural cycles in vitro. Clin Exp Obstet Gynecol 21 (1994) 14-23
7. Klein N.A., Illingworth P.J., Groome N.P., McNeilly A.S., Battaglia D.E., and Soules M.R. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81 (1996) 2742-2745
8. Eldar-Geva T., Robertson D.M., Cahir N., Groome N., Gabbe M.P., Maclachlan V., et al. Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. J Clin Endocrinol Metab 85 (2000) 607-613
9. Ortmann O., and Diedrich K. Pituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analogues. Hum Reprod 14 Suppl 1 (1999) 194-206
10. Hughes E.G., Robertson D.M., Handelsman D.J., Hayward S., Healy D.L., and de Kretser D.M. Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome. J Clin Endocrinol Metab 70 (1990) 358-364
11. Bo-Abbas Y.Y., Martin K.A., Liberman R.F., Cramer D.W., and Barbieri R.L. Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist. Fertil Steril 75 (2001) 694-699
12. Andersen C.Y., Westergaard L.G., Sinosich M.J., and Byskov A.G. Human preovulatory follicular fluid: inhibin and free steroids related to optimal follicular maturation in ovarian stimulation regimes and possible function in ovulation. Hum Reprod 7 (1992) 765-769
13. Barreca A., Del Monte P., Ponzani P., Artini P.G., Genazzani A.R., and Minuto F. Intrafollicular insulin-like growth factor-II levels in normally ovulating women and in patients with polycystic ovary syndrome. Fertil Steril 65 (1996) 739-745
14. Ozornek M.H., Bielfeld P., Krussel J.S., Hirchenhain J., Jeyendran R.S., and Koldovsky U. Epidermal growth factor and leukemia inhibitory factor levels in follicular fluid. Association with in vitro fertilization outcome. J Reprod Med 44 (1999) 367-369
15. Al-Inany H., and Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 17 (2002) 874-885
16. Cunha-Filho J.S., Lemos N., Stein N., Laranjeira A., and Passos E.P. Vascular endothelial growth factor and inhibin A in follicular fluid of infertile patients who underwent in vitro fertilization with a gonadotropin-releasing hormone antagonist. Fertil Steril 83 (2005) 902-907
17. Weiss J.M., Krautmacher B., Polack S., Diedrich K., and Ortmann O. Actions of GnRH antagonists on IGF-II, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells. Eur J Endocrinol 149 (2003) 31-37
18. Garcia-Velasco J.A., Isaza V., Vidal C., Landazabal A., Remohi J., Simon C., et al. Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix). Hum Reprod 16 (2001) 2533-2539
19. Lin Y., Kahn J.A., and Hillensjo T. Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?. Hum Reprod 14 (1999) 885-888
20. Ding J., and Foxcroft G.R. Epidermal growth factor enhances oocyte maturation in pigs. Mol Reprod Dev 39 (1994) 30-40
21. Yeh J., Lee G.Y., and Anderson E. Presence of transforming growth factor-alpha messenger ribonucleic acid (mRNA) and absence of epidermal growth factor mRNA in rat ovarian granulosa cells, and the effects of these factors on steroidogenesis in vitro. Biol Reprod 48 (1993) 1071-1081
22. Adashi E.Y., Resnick C.E., D'Ercole A.J., Svoboda M.E., and Van Wyk J.J. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev 6 (1985) 400-420
23. Fried G., Remaeus K., Harlin J., Krog E., Csemiczky G., Aanesen A., et al. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization. J Assist Reprod Genet 20 (2003) 167-176
24. Oosterhuis G.J., Vermes I., Lambalk C.B., Michgelsen H.W., and Schoemaker J. Insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in fluid from human stimulated follicles. Hum Reprod 13 (1998) 285-289
25. Chang C.L., Wang T.H., Horng S.G., Wu H.M., Wang H.S., and Soong Y.K. The concentration of inhibin B in follicular fluid: relation to oocyte maturation and embryo development. Hum Reprod 17 (2002) 1724-1728
26. Vitale A., Lancuba S., Ballerini M.G., Groome N., Campo S., and Tesone M. Inhibin A and B levels in follicular fluid of patients undergoing assisted reproduction: correlation with hormone levels and pregnancy. Fertil Steril 75 (2001) 221-222
27. Ocal P., Aydin S., Cepni I., Idil S., Idil M., Uzun H., et al. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome?. Eur J Obstet Gynecol Reprod Biol 115 (2004) 194-199